• 专利标题:   Sustained-release patch used as medicine for treating atherosclerosis, comprises delivery system comprising matrix and metal nanoparticles and medicine containing proprotein convertase subtilisin/kexin type 9 monoclonal antibody.
  • 专利号:   CN115590842-A
  • 发明人:   ZHANG C, SU F, HE B, ZHANG Q
  • 专利权人:   SHANGHAI CHEST HOSPITAL
  • 国际专利分类:   A61K039/395, A61K047/02, A61K047/04, A61K047/34, A61K047/36, A61K009/70, A61P009/10
  • 专利详细信息:   CN115590842-A 13 Jan 2023 A61K-009/70 202323 Chinese
  • 申请详细信息:   CN115590842-A CN11293301 21 Oct 2022
  • 优先权号:   CN11293301

▎ 摘  要

NOVELTY - Proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibody containing sustained-release patch comprises a delivery system and medicine, where the delivery system comprises a matrix and metal nanoparticles and the medicine is PCSK9 monoclonal antibody. USE - The PCSK9 monoclonal antibody sustained-release patch is used as medicine for treating atherosclerosis (claimed).